Sonja J Gill

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Endoplasmic Reticulum Stress

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Anna D Staniszewska, Domenic Pilger, Sonja J Gill, Kunzah Jamal, Natacha Bohin, Sofia Guzzetti, Jacob A Gordon, Gregory Hamm, Gill Mundin, Giuditta Illuzzi, Andy Pike, Lisa McWilliams, Gareth A Maglennon, Jonathan Rose, Glen Hawthorne, Miguel A Cortés González, Christer Halldin, Peter Johnström, Magnus Schou, Susan E Critchlow, Stephen E Fawell, Jeffrey W Johannes, Elisabetta Leo, Barry R Davies, Sabina Cosulich, Jann N Sarkaria, Lenka Oplustil O'Connor, Petra Hamerlik
Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Giuditta Illuzzi, Anna D Staniszewska, Sonja J Gill, Andy Pike, Lisa McWilliams, Susan E Critchlow, Anna Cronin, Stephen E Fawell, Glen Hawthorne, Kunzah Jamal, Jeffrey W Johannes, Emilyanne Leonard, Ruth Macdonald, Gareth A Maglennon, Jenni Nikkilä, Lenka Oplustil O'Connor, Aaron Smith, Harriet Southgate, Joanne Wilson, James W T Yates, Sabina Cosulich, Elisabetta Leo
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Sonja J Gill, Paul W G Wijnhoven, Jacqueline H L Fok, Rebecca L Lloyd, Jonathan Cairns, Joshua Armenia, Jenni Nikkilä, Alan Lau, Christopher J Bakkenist, Susan M Galbraith, Conchita Vens, Lenka Oplustil O'Connor
Radiopotentiation Profiling of Multiple Inhibitors of the DNA Damage Response for Early Clinical Development. Molecular cancer therapeutics 20 (9) (2021)